MedPath
FDA Product

North American Coral Snake Antivenin (Equine)

Product approved by U.S. Food and Drug Administration (US)

Basic Information

North American Coral Snake Antivenin (Equine)

0008-0423

Regulatory Information

0008-0423

BLA101099

C73585

July 1, 2019

USA

These highlights do not include all the information needed to use North American Coral Snake Antivenin (Equine) safely and effectively. See full prescribing information for North American Coral Snake Antivenin (Equine). North American Coral Snake Antivenin (Equine)Lyophilized Powder for Solution for Intravenous InjectionInitial U.S. Approval: 1967

HUMAN PRESCRIPTION DRUG LABEL

7

Company Information

Active Ingredients

PHENOL

Code: 339NCG44TV

Class Code: IACT

THIMEROSAL

Code: 2225PI3MOV

Class Code: IACT

CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE)

Quantity: 250 [arb'U] in 10 mL

Code: Y605XBM2GL

Class Code: ACTIB

Active Moieties

CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE)

Code: Y605XBM2GL

© Copyright 2025. All Rights Reserved by MedPath